The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
- Neuropore Therapies Inc.
Filter Results (2)
-
Synuclein Therapeutic Acceleration Program, 2013Development of the Alpha-Synuclein Stabilizer NPT200-11 for the Treatment of Parkinson’s Disease
Objective/Rationale:
A role for the synaptic protein alpha-synuclein in Parkinson’s disease is suggested by human genetic studies, the histopathology in patients with Parkinson’s disease and studies... -
Alpha-Synuclein Therapeutics, 2010A Pre-Clinical Study in a PD-like Transgenic Pre-Clinical Model of a Novel Isoindole Compound that Selectively Blocks Alpha-Synuclein Oligomerization
Objective/Rationale:
The damage to neuronal cells and connections in Parkinson’s disease is associated with the abnormal accumulation of a neuronal protein denominated alpha-synuclein. We have...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.